Note: Instant PDF download after purchase.

Key Trends

• Base and prime editing

• AI-assisted guide RNA design and off-target prediction

• In vivo and personalised therapies

Featured Reports

• Drivers, Restraints and Opportunities

• Key Players: CRISPR Therapeutics, Editas Medicine, Intellia Therapeutics, Beam Therapeutics, Verve Therapeutics, Caribou Biosciences, Synthego, Thermo Fisher Scientific

• Global Value: USD 3.64B (2026) to approx. USD 9.5B (2035), 11.24% CAGR

• Trends and Company Overview

Benefits

• Base-case forecast anchored on a published projection, with scope disclosure

• 6-tab Excel model with live formulas

• End-user and regional analysis

Need a custom report? Contact Solid Market Research at www.solidmarketresearch.com.

Tags: CRISPR, gene editing, biotech, market research report